KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $13.4 million.

  • Chemed's Other Non-Current Liabilities rose 150.35% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 150.35%. This contributed to the annual value of $13.4 million for FY2024, which is 281.47% up from last year.
  • According to the latest figures from Q3 2025, Chemed's Other Non-Current Liabilities is $13.4 million, which was up 150.35% from $13.2 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Other Non-Current Liabilities registered a high of $27.6 million during Q3 2021, and its lowest value of $9.6 million during Q4 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $13.0 million (2024), whereas its average is $14.7 million.
  • The largest annual percentage gain for Chemed's Other Non-Current Liabilities in the last 5 years was 23843.52% (2021), contrasted with its biggest fall of 6330.07% (2021).
  • Quarter analysis of 5 years shows Chemed's Other Non-Current Liabilities stood at $9.6 million in 2021, then grew by 25.87% to $12.1 million in 2022, then grew by 7.14% to $13.0 million in 2023, then rose by 2.81% to $13.4 million in 2024, then decreased by 0.01% to $13.4 million in 2025.
  • Its last three reported values are $13.4 million in Q3 2025, $13.2 million for Q2 2025, and $13.1 million during Q1 2025.